Retour
Prix Hua Medicine (Shanghai) Ltd. (HUMDF)
Graphique du cours de l'action HUMDF
HUMDF Gagner
Hua Medicine (Shanghai) Ltd.
$0
0%
$0
À la fermeture : Feb 12, 16:00:00 GMT-5
$0
0%
$0
Pré-Marché: Feb 13, 06:03:23 GMT-5
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que Hua Medicine ?
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.